hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

Jules C Hancox, Dario Melgari, Christopher E Dempsey, Kieran E Brack, John Mitcheson, G André Ng

Research output: Contribution to journal › Article (Academic Journal) › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	177-9
Number of pages	3
Journal	Therapeutic Advances in Drug Safety
Volume	6
Issue number	4
DOIs	https://doi.org/10.1177/2042098615595546
Publication status	Published - Aug 2015

Access to Document

@article{2757a388ac8842af940bfc339a4b1621,

title = "hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes",

author = "Hancox, {Jules C} and Dario Melgari and Dempsey, {Christopher E} and Brack, {Kieran E} and John Mitcheson and Ng, {G Andr{\'e}}",

year = "2015",

month = aug,

doi = "10.1177/2042098615595546",

language = "English",

volume = "6",

pages = "177--9",

journal = "Therapeutic Advances in Drug Safety",

issn = "2042-0986",

publisher = "SAGE Publications Ltd",

number = "4",

}

TY - JOUR

T1 - hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

AU - Hancox, Jules C

AU - Melgari, Dario

AU - Dempsey, Christopher E

AU - Brack, Kieran E

AU - Mitcheson, John

AU - Ng, G André

PY - 2015/8

Y1 - 2015/8

U2 - 10.1177/2042098615595546

DO - 10.1177/2042098615595546

M3 - Article (Academic Journal)

C2 - 26301071

SN - 2042-0986

VL - 6

SP - 177

EP - 179

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

IS - 4

ER -